Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishing 18F-PBR06 PET Imaging as a Viable Pharmacodynamic Endpoint in MSA

NCT03033680 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT03033680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03033680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishing 18F-PBR06 PET Imaging as a Viable Pharmacodynamic Endpoint in MSA
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
March 24, 2017
Completion date
January 15, 2021
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

msa